Partner; March 2016 DASGIP- Eppendorf in Biopharma Reporter: Eppendorf addressing stem cell scale-up challenges in Horizon 2020 Project; March 31st, 2016 Transscript Biocom: Stammzellen für den medizinischen [...] “fills a gap in the European conference landscape”. The program covered some of the most important challenges in stem cell bioprocessing today: Process design, scale-up, and product safety. After a warm welcome [...] hiPSC-cardiomyocyte and macrophage production forward” Robert Zweigerdt highlighted a further challenge on the route to the clinical use of hiPSC-derived cells - the production of high cell numbers. One

Focus Functional Analysis of (Rare) Genetic Variants Understanding genetic variants remains a major challenge in human genetics. Although advanced sequencing technologies allow us to identify even complex genomic [...] human monogenic disorders caused by ACTB or ACTG1 variants has yet to be systematically explored. Challenges in assigning pathogenicity and in linking individual variants to specific NMAs hamper accurate [...] diagnosis. Even after a specific NMA is diagnosed, clinical management and providing prognosis is challenging due to limited data. Our group aims to uncover the mechanisms underlying NMA and explore the c

Steffen(at)mh-hannover.de 0511 532 8858 Hakim, Cosima Hakim.Cosima(at)mh-hannover.de 0511 532 2980 Hall, Stefanie Hall.Stefanie(at)mh-hannover.de 0511 532 2824 Henke, Tina Henke.Tina(at)mh-hannover.de 0511 532

Dittrich Tel.: + 49 511 / 532 9785 Email: dittrich.anna-maria[at]mh-hannover.de Unser Team Dr. Olga Halle Postdoktorandin Laborleitung Claudia Kessemeier MTA Dr. Khatuna Lobjanidze PhD Studentin FWJ jährlich

von Wasielewski R, Lindschau C, Kirsch T, de Groot K, Laudeley R, Niemczyk E, Guler F, Menne J, Haller H, Fliser D: Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently [...] 34(4): 349-53 Fiebeler A, Park JK, Muller DN, Lindschau C, Mengel M, Merkel S, Banas B, Luft FC, Haller H: Growth arrest specific protein 6/Axl signaling in human inflammatory renal diseases. Am J Kidney [...] 9(5): 371-86 Mengel M, Jonigk D, Marwedel M, Kleeberger W, Bredt M, Bock O, Lehmann U, Gwinner W, Haller H, Kreipe H: Tubular Chimaerism occurs regularly in Renal Allografts and is not correlated to the

6(2): 90-96 Bräsen JH , Khalifa A , Schmitz J , Dai W , Einecke G, Schwarz A, Hallensleben M, Schmidt BM, Kreipe HH , Haller H, von Vietinghoff S: Macrophage density in early surveillance biopsies predicts [...] 96(6): 887-894 Bräsen JH , Khalifa A , Schmitz J , Dai W , Einecke G, Schwarz A, Hallensleben M, Schmidt BMW, Kreipe HH , Haller H, von Vietinghoff S: Macrophage density in early surveillance biopsies predicts [...] Kraemer TD, Wrede C, Hegermann J, Bräsen JH , Bockmeyer C , Ulrich Becker J , Ochs M, Gwinner W, Haller H, Melk A, Schmitt R: Autophagy in kidney transplants of sirolimus treated recipients. J Nephropathol

kshop (Stefanie Weuffen, Claudia Froböse) Kamingespräche Gute Wissenschaftliche Praxis (Dr. Olga Halle) Gute Lehre (Prof'in Sandra Steffens) Habilitation

endlich ein Aufbruch? Eine weihnachtlich und wissenschaftlich gestimmte Antwort gab Professor Hermann Haller, Direktor der MHH-Klinik für Nephrologie, mit seinem Vortrag „The Icing on the Cake – Der Zucker [...] Adventsvorlesung: The Icing on the Cake – Der Zucker in der Transplantationsmedizin Prof. Hermann Haller, Klinik für Nieren- und Hochdruckerkrankungen Podiumsdiskussion: Transplantationsmedizin in Deutschland:

2018 . Damilola Dawodu NIGERIA supervisor: Dr. Yulia Kiyan, Nephrology, OE 6840 Prof. Dr. Hermann Haller, Nephrology, OE 6840, project: Bone-vascular axis in chronic kidney disease: molecular mechanisms [...] Supervisor: Prof. Dr. Jan-Henning Klusmann, Direktor Universitätsklinikum und Poliklinik Pädiatrie I, Halle/Saale Dr. Dirk Heckl, Ped. Hematology, OE 6780, project: High-throughput functional characterization

2011; 21(6): 672-7 Habicht A, Bröker V , Blume C, Lorenzen J, Schiffer M, Richter N, Klempnauer J, Haller H, Lehner F, Schwarz A: Increase of infectious complications in ABO-incompatible kidney transplant [...] Kümpers P, Gueler F, David S, Van Slyke P, Dumont DJ, Park JK, Bockmeyer CL , Parikh SM, Pavenstädt H, Haller H, Sushakova N: The synthetic Tie2 agonist peptide vasculotide protects against vascular leakage [...] infection of the lungs.] Pathologe 2011; 32(5): 411-7 [German] Lorenzen JM, Krauter J, Länger F , Haller H, Gwinner W: Necrotizing fasciitis and acute kidney injury in a patient with acute myelogenous